Eyenovia Inc (USD)
EYEN
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range3.13 | 3.37
52-Wk Range2.40 | 6.98
Last Close3.30
Mkt Cap (m)56.43
Dividend yield-
ISINUS30234E1047
Volume61,657
Exchange VenueNAS

Company Profile

Eyenovia Inc is a clinical stage biopharmaceutical company. It is engaged in developing a pipeline of ophthalmology products utilizing patented piezo-print technology to deliver micro-therapeutics topically to the eye.

Key Information
Price/Earning-
Price/Book3.44
Price/Sales-
P/CF-
Rev Growth (3 year avg)0.00
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-157.09
Debt/Equity-

Legal Documents

Prospectus
en 11/07/2019
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)--
Operating Income (m)---4-4-5-17
Net Income (m)---4-4-5-17
Basic EPS---0.43-0.36-0.52-1.82
Avg. Diluted Shares Outstanding (m)--1010109
Balance Sheet
USD201320142015201620172018
Current Assets (m)--33520
Non Current Assets (m)--
Total Assets (m)--33620
Current Liabilities (m)--13
Total Liabilities (m)------
Total Equity (m)--23517
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)---4-3-5-13
Capital Expenditure (m)--
Figures are quoted in USD unless stated otherwise
0.00 (0.00%)
$
3.30
Last Price